Medical Evaluation and Treatment of Urolithiasis

Pediatric Clinics of North America

Volumn 53, Issue 3, 2006, Pages 479-491

  Nicoletta, Julie A ^a   Lande, Marc B ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CYSTINURIA; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FLUID THERAPY; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; INCIDENCE; MEDICAL ASSESSMENT; METABOLIC PARAMETERS; NEPHROLITHIASIS; POPULATION RESEARCH; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; URINARY TRACT INFECTION; UROLITHIASIS; ADOLESCENT; CHILD; ELECTROLYTE DISTURBANCE; INFANT; METABOLIC DISORDER; METHODOLOGY; NEWBORN; PRESCHOOL CHILD; URINALYSIS; URINE;

URIC ACID;

ADOLESCENT; CALCIUM METABOLISM DISORDERS; CHILD; CHILD, PRESCHOOL; CYSTINURIA; HUMANS; HYPEROXALURIA; INFANT; INFANT, NEWBORN; METABOLIC DISEASES; URIC ACID; URINALYSIS; URINARY CALCULI;

EID: 33746663052     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2006.03.001     Document Type: Review

References (74)

1. Walther P.C., Lamm D., and Kaplan G.W. Pediatric urolithiases: a ten-year review. Pediatrics 65 6 (1980) 1068-1072
2. Troup C.W., Lawnicki C.C., Bourne R.B., et al. Renal calculus in children. J Urol 107 2 (1972) 306-307
3. Nimkin K., Lebowitz R.L., Share J.C., et al. Urolithiasis in a children's hospital: 1985-1990. Urol Radiol 14 3 (1992) 139-143
4. Miyake O., Kakimoto K., Tsujihata M., et al. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion. Urology 58 3 (2001) 493-497
5. Miyake O., Yoshimura K., Yoshioka T., et al. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis. Urol Res 26 3 (1998) 209-213
6. Fujisawa M., Morikawa M., Arima S., et al. Analysis of the urinary risk factors of urolithiasis in healthy children. Japanese Journal of Urology 80 8 (1989) 1187-1194
7. Gearhart J.P., Herzberg G.Z., and Jeffs R.D. Childhood urolithiasis: experiences and advances. Pediatrics 87 4 (1991) 445-450
8. Diamond D.A. Clinical patterns of paediatric urolithiasis. Br J Urol 68 2 (1991) 195-198
9. Perrone H.C., dos Santos D.R., Santos M.V., et al. Urolithiasis in childhood: metabolic evaluation. Pediatr Nephrol 6 1 (1992) 54-56
10. Sarkissian A., Babloyan A., Arikyants N., et al. Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991-1999. Pediatr Nephrol 16 9 (2001) 728-732
11. Gillespie R.S., and Stapleton F.B. Nephrolithiasis in children. Pediatr Rev 25 4 (2004) 131-138
12. Bleyer A., and Agus Z.S. Approach to nephrolithiasis. Kidney 25 2 (1992) 1-10
13. Milliner D.S., and Murphy M.E. Urolithiasis in pediatric patients. Mayo Clin Proc 68 3 (1993) 241-248
14. Lim D.J., Walker III R.D., Ellsworth P.I., et al. Treatment of pediatric urolithiasis between 1984 and 1994. J Urol 156 2 Pt 2 (1996) 702-705
15. Choi H., Snyder III H.M., and Duckett J.W. Urolithiasis in childhood: current management. J Pediatr Surg 22 2 (1987) 158-164
16. Stapleton F.B., McKay C.P., and Noe H.N. Urolithiasis in children: the role of hypercalciuria. Pediatr Ann 16 12 (1987) 980-992
17. Lande M.B., Varade W., Erkan E., et al. Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol 20 (2005) 491-494
18. Polinsky M.S., Kaiser B.A., and Baluarte H.J. Urolithiasis in childhood. Pediatr Clin North Am 34 (1987) 683-710
19. Kraus S.J., Lebowitz R.L., and Royal S.A. Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol 29 8 (1999) 624-630
20. Robertson W.G. What is the aetiology of urinary calculi?. Pediatr Nephrol 10 6 (1996) 763
21. Milliner D.S. Epidemiology of calcium oxalate urolithiasis in man. In: Khan S.R. (Ed). Calcium oxalate in biological systems (1995), CRC Press, Boca Raton (FL) 169-188
22. Milliner D.S. Urolithiasis. In: Avner E.D., Harmon W.E., and Niaudet P. (Eds). Pediatric nephrology (2004), Lippincott Williams & Wilkins, Philadelphia 1091-1111
23. Moore E.S. Hypercalciuria in children. Contrib Nephrol 27 (1981) 20-32
24. Kruse K., Kracht U., and Kruse U. Reference values for urinary calcium excretion and screening for hypercalciuria in children and adolescents. Eur J Pediatr 143 1 (1984) 25-31
25. Vachvanichsanong P., Malagon M., and Moore E.S. Urinary tract infection in children associated with idiopathic hypercalciuria. Scand J Urol Nephrol 35 2 (2001) 112-116
26. Stapleton F.B. Idiopathic hypercalciuria: association with isolated hematuria and risk for urolithiasis in children: the Southwest Pediatric Nephrology Study Group. Kidney Int 37 2 (1990) 807-811
27. Garcia C.D., Miller L.A., and Stapleton F.B. Natural history of hematuria associated with hypercalciuria in children. Am J Dis Child 145 10 (1991) 1204-1207
28. Polito C., La Manna A., Cioce F., et al. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol 15 3-4 (2000) 211-214
29. Alon U.S., and Berenbom A. Idiopathic hypercalciuria of childhood: 4 to 11 year outcome. Pediatr Nephrol 14 10-11 (2000) 1011-1015
30. Favus M.J., Karnauskas A.J., Parks J.H., et al. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89 10 (2004) 4937-4943
31. Lloyd S.E., Pearce S.H.S., Fisher J.E., et al. A common molecular basis for three inherited molecular kidney stone diseases. Nature 379 (1996) 445-449
32. Stapleton F.B. Making a "dent" in hereditary hypercalciuric nephrolithiasis. J Pediatr 132 5 (1998) 764-765
33. Scheinman S.J. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53 1 (1998) 3-17
34. Reinhart S.C., Norden A.G.W., Lapsley M., et al. Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 5 (1995) 1451-1461
35. Igarashi T., Inatomi J., Ohara T., et al. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease. Kidney Int 58 2 (2000) 520-527
36. Bohles H., Brandl U., Schott G., et al. Clinical and chemical factors in kidney calculus formation in childhood: an analysis of 40 patients. Monatsschr Kinderheilkd 132 3 (1984) 158-162
37. Neuhaus T.J., Belzer T., Blau N., et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82 4 (2000) 322-326
38. th edition (1983), McGraw Hill, New York 204-228
39. Smith L.H. Enteric hyperoxaluria and other hyperoxaluric states. Nephrolithiasis (1980), Churchill-Livingstone, New York 138
40. Smith L.H. Diet and hyperoxaluria in the syndrome of idiopathic calcium oxalate urolithiasis. Am J Kidney Dis 17 4 (1991) 370-375
41. th edition (2001), McGraw-Hill, New York 3323-3367
42. Cramer S.D., Ferree P.M., Lin K., et al. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 8 11 (1999) 2063-2069
43. Milliner D.S., Wilson D.M., and Smith L.H. Phenotypic expression of primary hyperoxaluria: comparative features of type I and II. Kidney Int 59 1 (2001) 31-36
44. Milliner D.S., Eickholt J.T., Bergstralh E.J., et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 331 23 (1994) 1553-1558
45. Cochat P., Koch Nogueira P.C., et al. Primary hyperoxaluria in infants: medical, ethical, and economic issues. J Pediatr 135 6 (1999) 746-750
46. th edition (1983), McGraw-Hill, New York 1043-1114
47. rd edition (1986), WB Saunders, Philadelphia 1403-1442
48. th edition (1980), McGraw-Hill, New York 483
49. th edition (1983), McGraw-Hill, New York 1115-1119
50. Parks J.H., Worcester E.M., O'Connor R.C., et al. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 63 (2003) 255-265
51. Pak C.Y., Sakhaee K., Moe O., et al. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61 3 (2003) 523-527
52. Maalouf N.M., Sakhaee K., Parks J.H., et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65 (2004) 1422-1425
53. Bruno M., and Marangella M. Cystinuria: recent advances in pathophysiology and genetics. Contrib Nephrol 122 (1997) 173-177
54. Goodyer P., Boutros M., and Rozen R. The molecular basis of cystinuria: an update. Exp Nephrol 8 3 (2000) 123-127
55. Purroy J., Bisceglia L., Calonge M.J., et al. Genomic structure and organization of the human rBAT gene (SLC3A1). Genomics 37 2 (1996) 249-252
56. Chesney R.W. Mutational analysis of patients with cystinuria detected by a genetic screening network: powerful tools in understanding the several forms of the disorder. Kidney Int 54 1 (1998) 279-280
57. Feliubadalo L., Font M., Purroy J., et al. Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo, + AT) of rBAT. Nat Genet 23 1 (1999) 52-57
58. Goodyer P., Saadi I., Ong P., et al. Cystinuria subtype and the risk of nephrolithiasis. Kidney Int 54 1 (1998) 56-61
59. Rosenberg L.E., Downing S., Durant J.L., et al. Cystinuria: biochemical evidence for three genetically distinct diseases. J Clin Invest 45 3 (1966) 365-371
60. Alon U.S., Zimmerman H., and Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis: revisited. Pediatr Nephrol 19 (2004) 516-520
61. Pietrow P.K., Pope IV J.C., Adams M.C., et al. Clinical outcome of pediatric stone disease. J Urol 167 2 Pt 1 (2002) 670-673
62. Silver J., Rubinger D., Friedlaender M.M., et al. Sodium-dependent idiopathic hypercalciuria in renal stone formers. Lancet 2 8348 (1983) 484-486
63. Lewandowski S., and Rodgers A.L. Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345 (2004) 17-34
64. Coe F., Favus M., Pak C., et al. Kidney stones: medical and surgical management (1996), Lippincott-Raven, Philadelphia 759-785
65. Elliott W.J. Glucose and cholesterol elevations during thiazide therapy: intention-to-treat versus actual on-therapy experience. Am J Med 99 (1995) 261-269
66. Curhan G.C. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328 (1993) 833-838
67. Curhan G.C., Willett W.C., and Speizer F.E. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126 (1997) 497-504
68. Sakhaee K., Baker S., Zerwekh J., et al. Limited risk of kidney stone formation during long term calcium citrate supplementation in nonstone forming subjects. J Urol 152 (1994) 324-327
69. Levine B.S., Rodman J.S., Wienerman S., et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Am J Clin Nutr 60 (1994) 592-596
70. Domrongkitchaiporn S., Ongphiphadhanakul B., Stitchantrakul W., et al. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen. Maturitas 26 (2002) 149-156
71. Wahl C., and Hess B. Kidney calculi: is nutrition a trigger or treatment. Rev Ther 57 (2000) 138-145
72. Lieberman M., and Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 163 (2000) 1565-1569
73. Fetner C.D., Barilla D.E., Townsend J., et al. Effect of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. J Urol 120 4 (1978) 399-401
74. Ettinger B., Citon J., and Tang A. Controlled studies in stone-prophylaxis: comparison of placebo versus allopurinol/chlorthalidone/magnesium hydroxide. Urol Res 12 (1984) 49-55